These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 6112447

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2.
    Defreyn G, Deckmyn H, Vermylen J.
    Thromb Res; 1982 Jun 15; 26(6):389-400. PubMed ID: 7051416
    [Abstract] [Full Text] [Related]

  • 3. The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in man.
    Fischer S, Struppler M, Böhlig B, Bernutz C, Wober W, Weber PC.
    Circulation; 1983 Oct 15; 68(4):821-6. PubMed ID: 6352080
    [No Abstract] [Full Text] [Related]

  • 4. Characterization of imidazo[1,5-a]pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical models.
    Ku EC, McPherson SE, Signor C, Chertock H, Cash WD.
    Biochem Biophys Res Commun; 1983 May 16; 112(3):899-906. PubMed ID: 6687803
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y, Hattori R, Takatsu Y, Nakajima H, Wakabayashi A, Kawai C, Kayama N, Hiraku S, Inagawa T, Tsubojima M.
    Circulation; 1984 Oct 16; 70(4):599-605. PubMed ID: 6434196
    [Abstract] [Full Text] [Related]

  • 9. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.
    Parry MJ.
    Br J Clin Pharmacol; 1983 Oct 16; 15 Suppl 1(Suppl 1):23S-29S. PubMed ID: 6401997
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
    Rajtar G, Cerletti C, Castagnoli MN, Bertelé V, de Gaetano G.
    Biochem Pharmacol; 1985 Feb 01; 34(3):307-10. PubMed ID: 3918536
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Manipulation of the local thromboxane and prostacyclin balance in vivo by the antithrombotic compounds dazoxiben, acetylsalicylic acid and nafazatrom.
    Deckmyn H, Van Houtte E, Verstraete M, Vermylen J.
    Biochem Pharmacol; 1983 Sep 15; 32(18):2757-62. PubMed ID: 6578796
    [Abstract] [Full Text] [Related]

  • 15. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
    Hardee MM, Moore JN, Hardee GE.
    Res Vet Sci; 1986 Mar 15; 40(2):152-6. PubMed ID: 3517992
    [Abstract] [Full Text] [Related]

  • 16. The effects of a new thromboxane synthetase inhibitor, CGS-13080, in man.
    MacNab MW, Foltz EL, Graves BS, Rinehart RK, Tripp SL, Feliciano NR, Sen S.
    J Clin Pharmacol; 1984 Mar 15; 24(2-3):76-83. PubMed ID: 6371062
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
    Reilly IA, Doran JB, Smith B, FitzGerald GA.
    Circulation; 1986 Jun 15; 73(6):1300-9. PubMed ID: 2938849
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of platelet aggregation by 1-alkylimidazole derivatives, thromboxane A synthetase inhibitors.
    Kayama N, Sakaguchi K, Kaneko S, Kubota T, Fukuzawa T, Kawamura S, Yoshimoto T, Yamamoto S.
    Prostaglandins; 1981 Apr 15; 21(4):543-54. PubMed ID: 7196056
    [Abstract] [Full Text] [Related]

  • 20. In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the rat.
    Maguire ED, Wallis RB.
    Thromb Res; 1983 Oct 01; 32(1):15-27. PubMed ID: 6689221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.